Zhihong Zeng
The University of Texas MD Anderson Cancer Center(US)Shanghai University of Engineering Science(CN)Hunan University(CN)Changsha University(CN)University of Michigan(US)Shanghai Research Institute of Chemical Industry(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML(2008)509 cited
- → MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy(2005)395 cited
- → XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia(2016)264 cited
- → Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin(2016)203 cited
- → ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies(2016)199 cited
- → Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias(2006)186 cited